About Kenson Ventures, LLC | The Kenson Ventures Team | Mission
About Kenson Ventures, LLC
Kenson Ventures, LLC ("Kenson Ventures") is a California-based venture
investment limited liability company founded in 1999. It is located in
scenic Palo Alto, a town 25 miles south of San Francisco and in the hub of
Kenson Ventures provides seed money/funds and
strategic advice to start-ups, partnerships, and established companies
focusing in the biotechnology and life science areas. Kenson
Ventures also considers and participates in co-investment with other
institutions. The range of investment varies from $500,000 to $3 million
U.S. dollars. Since Kenson funds are often
accompanied by co-investments from affiliated institutions, the actual
amount of investment could be much greater than that provided by us.
Majority of the investment are made in private companies in the United
States. A Kenson Ventures representative normally
serves on the board (member of the Board or Business Advisory Board) in
which it has a vested interest.
We, at Kenson Ventures, understand the
challenges of building a successful company. Our team is dedicated in
assisting companies with strong growth potential. Our strength is in our
knowledge base and industry experiences in building biotechnology companies
in the past. When we make an investment, we do our best to provide growth
strategy, resources and the contact network to assure success of the
Kenson Ventures consistently strives to make
fruitful investment work. Our primary focus is on emerging-growth
companies. We may also make investments in late-stage companies. In the
short time since Kenson Ventures' inception, we
have been involved in and financed over 20 rapidly growing companies
representing a broad spectrum of technology platforms. The engagement of
these companies ranges from the development of novel drugs, discovery of
genomics-based drug targets and leads, to the development of research tools
in molecular and cellular biology. For a listing of our previous and
current investments, please visit our Portfolio Companies section.
Kenneth Fong, Ph.D., is the Chairman of Kenson Ventures, LLC. Kenson
specializes in venture financing and strategic consulting to biotech
companies. As of January 2016, Kenson has
investments that mostly fall into 3 major categories: a) Innovative
Research Tools, b) Platform Technologies, and c) Drug Development. Prior to
founding Kenson, Dr. Fong is the founder and former
CEO of CLONTECH Laboratories, that was acquired by
Becton Dickinson (BD) in late 1999. CLONTECH is the leader in the
Molecular/Cell Biology market and in the last 4 years before its
acquisition, the company had experienced an average growth rate of 36% a
year. The company also had 48 consecutive quarters of double-digit growth
and profits. In 1994, 1995, 1998, and 1999, CLONTECH was selected as one of
the fastest-growing companies in the San Francisco Bay Area. Dr. Fong's
past experience is best suited to young companies and those desire to grow
more rapidly. He is also adept at crafting development strategy and
realistic implementation plan to promote the long-term growth of company.
Dr. Fong obtained his Ph.D. from Indiana University.
Joseph C.-C. Huang, Ph.D., is a Vice
President at Kenson Ventures, LLC. Dr. Huang has
extensive knowledge and experience in the biotech industry. He is an expert
in the screening and selecting portfolio companies for investment. Before Kenson, Dr. Huang was the Head of Molecular Biomedical
Research Department at CLONTECH Laboratories, Inc. (1995-1999). He was
responsible for setting up a new department and managing multi-million
dollar therapeutic target discovery contract research programs for several
major pharmaceutical companies. Prior to CLONTECH, he was a senior
scientist and project leader at Genelabs, Inc.
(1986-1995). He was involved in molecular cloning of novel hepatitis
viruses as well as in developing diagnostic tests for detecting hepatitis
viruses. Dr. Huang also participated in developing new tools for use in
screening small molecule drugs. Before Genelabs,
he was a postdoctoral fellow in the laboratory of Dr. Michael Bishop, a
Nobel Laureate, at University of California, San Francisco. Dr. Huang
received his Ph.D. in Chemistry from University of California, Berkeley.
Kenson Ventures is focused on building
successful companies and creating values in these companies by providing
seasoned and sound strategic advice in addition to financial assistance.
Our secondary aim is to assist in the
acceleration of basic and drug discovery that promote the development of
new and better therapeutic drugs.